Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.

By V. Summa, A. Petrocchi, F. Bonelli, B. Crescenzi, M. Donghi, M. Ferrara, F. Fiore, Cristina Gardelli, O. Gonzalez Paz, D. Hazuda and 13 more. Journal of Medicinal Chemistry, 2008

626 citations recorded by the source corpus.

Subfields: Infectious Diseases, Molecular Biology, Virology

View Paper: https://www.semanticscholar.org/paper/78671943e2679e71eb1b057d4a9cff9a9b9ca2ae

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Sandeepkumar Kothiwale
2. Jens Meiler
3. E. W. Lowe
4. Gregory Sliwoski
5. David Baker

Citations in the corpus

• Computational Methods in Drug Discovery (2014, background): “The discovery of this trench led to the development of raltegravir, by Merck (Summa et al., 2008).”